Medicare to Negotiate Lower Prices for Weight-Loss Drugs
Posted inDrugs (Pharmaceuticals) GLP-1 RAs (Drug) Health and Human Services Department Health Insurance and Managed Care Medicare Novo Nordisk A/S Obesity Ozempic (Drug) Prices (Fares, Fees and Rates) United States Politics and Government Weight

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
U.S. Unveils Price Limits for 10 Costly or Common Medications
Posted inAstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. Unveils Price Limits for 10 Costly or Common Medications

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations
Posted inAstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.